GB2443287B
(en )
2009-05-27
Methods, compositions and formulations for the treatment of thyroid eye disease
HK1144390A1
(en )
2011-02-18
Compositions for the treatment of neoplastic diseases
EP2056818A4
(en )
2009-09-23
Compositions and methods for neuroprotection
PH12013502192A1
(en )
2015-10-12
Antibodies against human angiopoietin 2
HUE041764T2
(en )
2019-05-28
Compositions suitable for treating collagen-mediated diseases
MX2012001974A
(en )
2012-04-11
Biaryl compounds and methods of use thereof.
SG169353A1
(en )
2011-03-30
Tamper resistant dosage forms
EP2475358A4
(en )
2014-01-08
Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
IL193747A0
(en )
2009-08-03
New therapeutic combinations for the treatment of depression
MX2010006204A
(en )
2011-03-16
5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases.
EP2365815A4
(en )
2016-11-30
Extracellular matrix compositions for the treatment of cancer
IL207546A0
(en )
2010-12-30
Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
WO2010121164A3
(en )
2011-02-24
1,4-benzodiazepinone compounds and their use in treating cancer
MX2010006206A
(en )
2011-03-04
5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
IL198723A0
(en )
2010-02-17
Methods and compositions for therapeutic treatment
EP2217238A4
(en )
2011-06-29
Methods and compositions for the treatment of proteinuric diseases
MX2010006388A
(en )
2010-06-25
Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists.
ZA200805761B
(en )
2010-03-31
Pharmaceutical composition for the treatment of nail disease
SG153015A1
(en )
2009-06-29
Herbal medicine for osteoporosis and related conditions
MX2009003740A
(en )
2009-04-22
Pegylated pth as pth receptor modulators and uses thereof.
GB0620695D0
(en )
2006-11-29
Composition and methods for the treatment of nurdegenerative disease
TN2009000131A1
(en )
2010-10-18
Pegylated pth as pth receptor modulators and uses thereof
EP2344528A4
(en )
2012-03-28
Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof
CA2853804C
(en )
2021-06-01
Anti-flush compositions
GB0621308D0
(en )
2006-12-06
An implement for administering medicine